Mutya Harsch
2021
In 2021, Mutya Harsch earned a total compensation of $1.3M as Chief Legal Officer, General Counsel and Secretary at VYNE Therapeutics, a 45% increase compared to previous year.
Compensation breakdown
| Bonus | $142,007 |
|---|---|
| Option Awards | $406,976 |
| Salary | $405,936 |
| Stock Awards | $345,587 |
| Other | $11,600 |
| Total | $1,312,106 |
Harsch received $407K in option awards, accounting for 31% of the total pay in 2021.
Harsch also received $142K in bonus, $405.9K in salary, $345.6K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Mutya Harsch's compensation ranked 7,785th out of 12,415 executives tracked by ExecPay. In other words, Harsch earned more than 37.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,785 out of 12,415 | 37th |
Division Manufacturing | 3,437 out of 5,505 | 38th |
Major group Chemicals And Allied Products | 1,528 out of 2,375 | 36th |
Industry group Drugs | 1,359 out of 2,096 | 35th |
Industry Pharmaceutical Preparations | 1,003 out of 1,546 | 35th |
Source: SEC filing on June 17, 2022.
Harsch's colleagues
We found two more compensation records of executives who worked with Mutya Harsch at VYNE Therapeutics in 2021.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021